StockData
XBiotech Inc. logo

XBiotech Inc. (XBIT) stock

XBITNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$1.96+0.00 (0.00%)

Close on Nov 13, 2026Market cap $59.76MP/E –Yield –

XBiotech price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

XBiotech's price to book ratio was 0.5× on Nov 11, 2026, against 0.4× a year earlier. Over the last 5 years it ranged from 0.4× to 1.2×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.5×+0.0
2025Dec 31, 20250.4×−0.2
2024Dec 31, 20240.6×+0.1
2023Dec 29, 20230.5×+0.1
2022Dec 30, 20220.4×−0.8
2021Dec 31, 20211.2×−0.1
2020Dec 31, 20201.3×−10.5
2019Dec 31, 201911.9×+8.0
2018Dec 31, 20183.9×+1.8
2017Dec 29, 20172.1×−2.5
2016Dec 30, 20164.6×+1.5
2015Dec 31, 20153.1×–

More XBiotech figures

See a number that looks wrong?